Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM. — المؤلف: Huemer, Florian — European journal of haematology 20191114

المؤلف
Huemer, Florian
النشر
European journal of haematology 20191114
الوصف
437-441 p.
الموضوعات
Aged؛ Aged, 80 and over؛ Antineoplastic Agents؛ Bcl-2-Like Protein 11؛ Biomarkers, Tumor؛ Bridged Bicyclo Compounds, Heterocyclic؛ DNA Methylation؛ Drug Resistance, Neoplasm